GC WellBeing Corporation (KOSDAQ:234690)
South Korea · Delayed Price · Currency is KRW 11,230
+490 (4.56%)
At close: Oct 23, 2026
GC WellBeing Market Cap
GC WellBeing has a market cap or net worth of 201.65 billion as of October 23, 2026. It is the 22,703rd most valuable company in the world and the 849th biggest in South Korea. Its market cap has increased by 20.63% in one year.
Market Cap
201.65B
Enterprise Value
287.44B
Revenue
192.21B
Global Rank
Country Rank
#849 South Korea
PE Ratio
41.75
ChartMarket Cap Chart
Since October 14, 2019, GC WellBeing's market cap has decreased from 221.90B to 201.65B, a decrease of -9.13%. That is a compound annual growth rate of -1.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 201.65B | 24.33% |
| Dec 30, 2025 | 162.19B | -9.18% |
| Dec 30, 2024 | 178.59B | 23.74% |
| Dec 28, 2023 | 144.33B | -1.22% |
| Dec 29, 2022 | 146.10B | -18.92% |
| Dec 30, 2021 | 180.19B | -27.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 282.43B |
| HEM Pharma | 215.19B |
| DAE HWA Pharmaceutical | 189.94B |
| Vivozon Pharmaceutical | 185.31B |
| NOVAREX | 168.07B |
| CellBion | 165.32B |
| Kyung Dong Pharmaceutical | 146.79B |
| HYUNDAI BIOLAND | 133.20B |